Download PDF
Thromb Haemost 1995; 74(05): 1382
DOI: 10.1055/s-0038-1649947
Letter To The Editor
Schattauer GmbH Stuttgart

Fatal Cerebral Venous Sinus Thrombosis Associated with the Factor V Leiden Mutation and the Use of Oral Contraceptives

Françoise Bridey
1   Service d’Hématologie et d’lmmunologie Biologiques et INSERM U 294, Paris, France
,
Michel Wolff
2   Clinique de Réanimation des Maladies Infectieuse, Paris, France
,
Jean Pierre Laissy
3   Service de Radiologie Viscérale, Hôpital Bichat-Claude Bernard, Paris, France
,
Véronique Morin
1   Service d’Hématologie et d’lmmunologie Biologiques et INSERM U 294, Paris, France
,
Martine Lefebvre
1   Service d’Hématologie et d’lmmunologie Biologiques et INSERM U 294, Paris, France
,
Dominique de Prost
1   Service d’Hématologie et d’lmmunologie Biologiques et INSERM U 294, Paris, France
› Author Affiliations
Further Information

Publication History

Received 29 June 1995

Accepted 20 July 1995

Publication Date:
10 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Vandenbroucke JP, Koster T, Briët E, Reitsma PH, Bertina RM, Rosendaal FR. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994; 344: 1453-1457
    CrossrefPubMedGoogle Scholar
  • 2 Gandrille S, Alhenc-Gelas M, Aiach M. A rapid screening method for the factor V Arg 506 Gln mutation. Blood Coag Fibrinol 1995; 6: 245-248
    CrossrefPubMedGoogle Scholar
  • 3 Bertina RM, Koeleman BP C, Koster T, Rosendaal RF, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation Factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67
    CrossrefPubMedGoogle Scholar
  • 4 Emmerich J, Poirier O, Evans A, Marques-Vidal P, Arveiler D, Luc G, Aiach M, Cambien F. Myocardial infarction, Arg 506 to Gln factor V mutation, and activated protein C resistance. Lancet 1995; 345: 321
    CrossrefPubMedGoogle Scholar